
Patient Perspectives on Buprenorphine/Naloxone Treatment in the Context of HIV Care
Author(s) -
James E. Egan,
Julie Netherland,
Jonathon Gass,
Ruth Finkelstein,
Linda Weiss
Publication year - 2011
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3182097561
Subject(s) - buprenorphine , (+) naloxone , context (archaeology) , medicine , patient satisfaction , substance abuse , naltrexone , opioid , psychiatry , intensive care medicine , nursing , paleontology , receptor , biology
Research has shown that buprenorphine/naloxone (bup/nx) is a safe and effective treatment for opioid dependence. Few reports, however, describe the patient perspective on bup/nx treatment and its integration into HIV care settings.